Latest News

Ampio Updates Regulatory and Clinical Trial Events

Date: November 25, 2020 | READ MORE >

Ampio’s Phase I Study for Inhaled Ampion Advances to 3rd Group of COVID-19 Patients with Respiratory Distress

Date: November 17, 2020 | READ MORE >

AMPIO’S PHASE I STUDY FOR INHALED AMPION ADVANCES TO 2ND GROUP OF COVID-19 PATIENTS WITH RESPIRATORY DISTRESS

Date: November 10, 2020 | READ MORE >

Ampio Pharmaceuticals, Inc. Provides Business Update and Reports Third Quarter 2020 Financial Results

Date: November 5, 2020 | READ MORE >

Ampio Pharmaceuticals, Inc. to Host Conference Call on November 5th

Date: November 2, 2020 | READ MORE >

AMPIO BEGINS PHASE 1 CLINICAL TRIAL OF INHALED AMPION FOR COVID-19 PATIENTS WITH RESPIRATORY DISTRESS

Date: October 28, 2020 | READ MORE >

Ampio Pharmaceuticals, Inc. to Present at the ROTH Capital Healthcare Event “COVID-19 Therapeutics in Development”

Date: October 27, 2020 | READ MORE >

Ampio Presents at Roth Capital Partners 2020 MedTech Innovation Forum Focusing on COVID-19 Clinical Trial Activities

Date: October 26, 2020 | READ MORE >

Ampio Publication Reports Beneficial Effects of Ampion on Important Transcription Factors in Inflammation

Date: October 8, 2020 | READ MORE >

FDA Grants IND and Approves Clinical Trial Protocol of Inhaled Ampion for COVID-19 Patients with Respiratory Distress

Date: September 21, 2020 | READ MORE >

AMPION PHASE I COVID-19 PATIENT TRIAL RESULTS FEATURED ON FOX NEWS (VIDEO)

Date: September 14, 2020 | READ MORE >

Ampio Reports Positive Results for Ampion Treatment in COVID-19 Patients

Date: September 9, 2020 | READ MORE >

Ampio Announces Enrollment Completion for Intravenous (“IV”) COVID-19 Clinical Trial & Provides Update on Osteoarthritis of the Knee (“OAK”) Clinical Trial

Date: September 4, 2020 | READ MORE >

Ampio Provides Update on COVID-19 Clinical Trial Activities

Date: August 19, 2020 | READ MORE >

Ampio Starts Patient Enrollment in its Ampion COVID-19 Program

Date: July 23, 2020 | READ MORE >

Ampio Reports a Publication on the Potential Benefits of Ampion for Treatment of a New COVID-19 related Syndrome

Date: July 20, 2020 | READ MORE >

Ampio to Start First Clinical Trial in COVID-19 Program

Date: June 19, 2020 | READ MORE >

Ampio Provides Update on COVID-19 Program

Date: May 22, 2020 | READ MORE >

Ampio Reports Acceptance of Publication on the Potential Benefits of Nebulized Ampion™ for COVID-19 Patients

Date: May 11, 2020 | READ MORE >

Ampio Pharmaceutical’s Application to the FDA for a Clinical Study of Ampion to Treat COVID-19 Induced Acute Respiratory Distress Syndrome (ARDS) featured in FOX News (VIDEO)

Date: April 2, 2020 | READ MORE >